MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells

We have previously reported a strong correlation between poor prognosis in childhood neuroblastoma (NB) patients and high-level expression of the transmembrane efflux pump, Multidrug Resistance-associated Protein (MRP1), in NB tumour tissue. In this study, we inhibited the endogenous expression of M...

Full description

Saved in:
Bibliographic Details
Published in:British journal of cancer 2001-11, Vol.85 (10), p.1564-1571
Main Authors: Peaston, A E, Gardaneh, M, Franco, A V, Hocker, J E, Murphy, K M, Farnsworth, M L, Catchpoole, D R, Haber, M, Norris, M D, Lock, R B, Marshall, G M
Format: Article
Language:English
Subjects:
Acids
Antineoplastic agents
Apoptosis
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cell death
Cell Differentiation
Cell Division
Chemotherapy
Clone Cells
Cloning
Cytotoxicity
Dose-Response Relationship, Drug
Down-Regulation
Drug Resistance
Epidemiology
Gene Expression
General aspects
Humans
In Situ Nick-End Labeling
Laboratories
Medical research
Medical sciences
Microscopy, Fluorescence
Molecular Medicine
MRP1 gene
Multidrug Resistance-Associated Proteins - genetics
Multidrug Resistance-Associated Proteins - metabolism
Multidrug Resistance-Associated Proteins - physiology
Neuroblastoma
Neuroblastoma - metabolism
Neuroblastoma - pathology
Oligonucleotides, Antisense - genetics
Oncology
Pharmacology. Drug treatments
Proteins
Proto-Oncogene Proteins c-bcl-2 - metabolism
Regular
regular-article
Transfection
Tretinoin - antagonists & inhibitors
Tumor Cells, Cultured
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c546t-2cdde2df73a15738de2e16d6ff77416d7ed3a2e8265e6d0e0db12d0ad6da91ab3
cites
container_end_page 1571
container_issue 10
container_start_page 1564
container_title British journal of cancer
container_volume 85
creator Peaston, A E
Gardaneh, M
Franco, A V
Hocker, J E
Murphy, K M
Farnsworth, M L
Catchpoole, D R
Haber, M
Norris, M D
Lock, R B
Marshall, G M
description We have previously reported a strong correlation between poor prognosis in childhood neuroblastoma (NB) patients and high-level expression of the transmembrane efflux pump, Multidrug Resistance-associated Protein (MRP1), in NB tumour tissue. In this study, we inhibited the endogenous expression of MRP1 in 2 different NB tumour cell lines by stably transfecting an MRP1 antisense expression vector ( MRP -AS). Compared with control cells, MRP -AS transfectant cells demonstrated a higher proportion of dead and morphologically apoptotic cells, spontaneous neuritogenesis, and, increased synaptophysin and neurofilament expression. Bcl-2 protein expression was markedly reduced in MRP -AS cells compared to controls. Conversely, we found that the same NB tumour cell line overexpressing the full-length MRP1 cDNA in sense orientation ( MRP -S) demonstrated resistance to the neuritogenic effect of the differentiating agent, all- trans -retinoic acid. Taken together, the results suggest that the level of MRP1 expression in NB tumour cells may influence the capacity of NB cells for spontaneous regression in vivo through cell differentiation and death. © 2001 Cancer Research Campaign http://www.bjcancer.com
doi_str_mv 10.1054/bjoc.2001.2144
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2363953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>954576083</sourcerecordid><originalsourceid>FETCH-LOGICAL-c546t-2cdde2df73a15738de2e16d6ff77416d7ed3a2e8265e6d0e0db12d0ad6da91ab3</originalsourceid><addsrcrecordid>eNqFkt9rFDEQx4Mo9lp99VGCYH3aa35tsvtSkOIvqCiiz2F2M3u3x15yJrtF_3uz3OG1Qu1DSIb5zGR-fAl5wdmSs1JdNJvQLgVjfCm4Uo_IgpdSFLwS5jFZMMZMwWrBTshpSpts1qwyT8kJ50YwpfSCNJ-_feV0hR4p_tpFTKkPng54gwONuJoGGDHRcY3UIYxrCt5R13cdRvRjD-NM56hd8Alp6KjHKYZmgDSGLdAWhyE9I086GBI-P9xn5Mf7d9-vPhbXXz58unp7XbSl0mMhWudQuM5I4KWRVTaQa6e7zhiVHwadBIGV0CVqx5C5hgvHwGkHNYdGnpHLfd7d1GzRtbnACIPdxX4L8bcN0Nu7Ht-v7SrcWCG1rEuZE7w5JIjh54RptNs-zS2AxzAlW5eqNJpVM3n-X9IIyfJ8ywfBvCglpRYZfPUPuAlT9HleVoi61vPJ0HIPtTGkFLH72xxndpaDneVgZznYWQ454OXtkRzxw_4z8PoAQGph6CL4tk9HTnGlNaszd7HnUnb5FcZjefd8_QdvnM9V</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229962996</pqid></control><display><type>article</type><title>MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells</title><source>Open Access: PubMed Central</source><creator>Peaston, A E ; Gardaneh, M ; Franco, A V ; Hocker, J E ; Murphy, K M ; Farnsworth, M L ; Catchpoole, D R ; Haber, M ; Norris, M D ; Lock, R B ; Marshall, G M</creator><creatorcontrib>Peaston, A E ; Gardaneh, M ; Franco, A V ; Hocker, J E ; Murphy, K M ; Farnsworth, M L ; Catchpoole, D R ; Haber, M ; Norris, M D ; Lock, R B ; Marshall, G M</creatorcontrib><description>We have previously reported a strong correlation between poor prognosis in childhood neuroblastoma (NB) patients and high-level expression of the transmembrane efflux pump, Multidrug Resistance-associated Protein (MRP1), in NB tumour tissue. In this study, we inhibited the endogenous expression of MRP1 in 2 different NB tumour cell lines by stably transfecting an MRP1 antisense expression vector ( MRP -AS). Compared with control cells, MRP -AS transfectant cells demonstrated a higher proportion of dead and morphologically apoptotic cells, spontaneous neuritogenesis, and, increased synaptophysin and neurofilament expression. Bcl-2 protein expression was markedly reduced in MRP -AS cells compared to controls. Conversely, we found that the same NB tumour cell line overexpressing the full-length MRP1 cDNA in sense orientation ( MRP -S) demonstrated resistance to the neuritogenic effect of the differentiating agent, all- trans -retinoic acid. Taken together, the results suggest that the level of MRP1 expression in NB tumour cells may influence the capacity of NB cells for spontaneous regression in vivo through cell differentiation and death. © 2001 Cancer Research Campaign http://www.bjcancer.com</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1054/bjoc.2001.2144</identifier><identifier>PMID: 11720446</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Acids ; Antineoplastic agents ; Apoptosis ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Cell death ; Cell Differentiation ; Cell Division ; Chemotherapy ; Clone Cells ; Cloning ; Cytotoxicity ; Dose-Response Relationship, Drug ; Down-Regulation ; Drug Resistance ; Epidemiology ; Gene Expression ; General aspects ; Humans ; In Situ Nick-End Labeling ; Laboratories ; Medical research ; Medical sciences ; Microscopy, Fluorescence ; Molecular Medicine ; MRP1 gene ; Multidrug Resistance-Associated Proteins - genetics ; Multidrug Resistance-Associated Proteins - metabolism ; Multidrug Resistance-Associated Proteins - physiology ; Neuroblastoma ; Neuroblastoma - metabolism ; Neuroblastoma - pathology ; Oligonucleotides, Antisense - genetics ; Oncology ; Pharmacology. Drug treatments ; Proteins ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; Regular ; regular-article ; Transfection ; Tretinoin - antagonists &amp; inhibitors ; Tumor Cells, Cultured</subject><ispartof>British journal of cancer, 2001-11, Vol.85 (10), p.1564-1571</ispartof><rights>The Author(s) 2001</rights><rights>2002 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Nov 2001</rights><rights>Copyright © 2001 Cancer Research Campaign 2001 Cancer Research Campaign</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c546t-2cdde2df73a15738de2e16d6ff77416d7ed3a2e8265e6d0e0db12d0ad6da91ab3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363953/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363953/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14146609$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11720446$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peaston, A E</creatorcontrib><creatorcontrib>Gardaneh, M</creatorcontrib><creatorcontrib>Franco, A V</creatorcontrib><creatorcontrib>Hocker, J E</creatorcontrib><creatorcontrib>Murphy, K M</creatorcontrib><creatorcontrib>Farnsworth, M L</creatorcontrib><creatorcontrib>Catchpoole, D R</creatorcontrib><creatorcontrib>Haber, M</creatorcontrib><creatorcontrib>Norris, M D</creatorcontrib><creatorcontrib>Lock, R B</creatorcontrib><creatorcontrib>Marshall, G M</creatorcontrib><title>MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>We have previously reported a strong correlation between poor prognosis in childhood neuroblastoma (NB) patients and high-level expression of the transmembrane efflux pump, Multidrug Resistance-associated Protein (MRP1), in NB tumour tissue. In this study, we inhibited the endogenous expression of MRP1 in 2 different NB tumour cell lines by stably transfecting an MRP1 antisense expression vector ( MRP -AS). Compared with control cells, MRP -AS transfectant cells demonstrated a higher proportion of dead and morphologically apoptotic cells, spontaneous neuritogenesis, and, increased synaptophysin and neurofilament expression. Bcl-2 protein expression was markedly reduced in MRP -AS cells compared to controls. Conversely, we found that the same NB tumour cell line overexpressing the full-length MRP1 cDNA in sense orientation ( MRP -S) demonstrated resistance to the neuritogenic effect of the differentiating agent, all- trans -retinoic acid. Taken together, the results suggest that the level of MRP1 expression in NB tumour cells may influence the capacity of NB cells for spontaneous regression in vivo through cell differentiation and death. © 2001 Cancer Research Campaign http://www.bjcancer.com</description><subject>Acids</subject><subject>Antineoplastic agents</subject><subject>Apoptosis</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Cell death</subject><subject>Cell Differentiation</subject><subject>Cell Division</subject><subject>Chemotherapy</subject><subject>Clone Cells</subject><subject>Cloning</subject><subject>Cytotoxicity</subject><subject>Dose-Response Relationship, Drug</subject><subject>Down-Regulation</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>Gene Expression</subject><subject>General aspects</subject><subject>Humans</subject><subject>In Situ Nick-End Labeling</subject><subject>Laboratories</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Microscopy, Fluorescence</subject><subject>Molecular Medicine</subject><subject>MRP1 gene</subject><subject>Multidrug Resistance-Associated Proteins - genetics</subject><subject>Multidrug Resistance-Associated Proteins - metabolism</subject><subject>Multidrug Resistance-Associated Proteins - physiology</subject><subject>Neuroblastoma</subject><subject>Neuroblastoma - metabolism</subject><subject>Neuroblastoma - pathology</subject><subject>Oligonucleotides, Antisense - genetics</subject><subject>Oncology</subject><subject>Pharmacology. Drug treatments</subject><subject>Proteins</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>Regular</subject><subject>regular-article</subject><subject>Transfection</subject><subject>Tretinoin - antagonists &amp; inhibitors</subject><subject>Tumor Cells, Cultured</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkt9rFDEQx4Mo9lp99VGCYH3aa35tsvtSkOIvqCiiz2F2M3u3x15yJrtF_3uz3OG1Qu1DSIb5zGR-fAl5wdmSs1JdNJvQLgVjfCm4Uo_IgpdSFLwS5jFZMMZMwWrBTshpSpts1qwyT8kJ50YwpfSCNJ-_feV0hR4p_tpFTKkPng54gwONuJoGGDHRcY3UIYxrCt5R13cdRvRjD-NM56hd8Alp6KjHKYZmgDSGLdAWhyE9I086GBI-P9xn5Mf7d9-vPhbXXz58unp7XbSl0mMhWudQuM5I4KWRVTaQa6e7zhiVHwadBIGV0CVqx5C5hgvHwGkHNYdGnpHLfd7d1GzRtbnACIPdxX4L8bcN0Nu7Ht-v7SrcWCG1rEuZE7w5JIjh54RptNs-zS2AxzAlW5eqNJpVM3n-X9IIyfJ8ywfBvCglpRYZfPUPuAlT9HleVoi61vPJ0HIPtTGkFLH72xxndpaDneVgZznYWQ454OXtkRzxw_4z8PoAQGph6CL4tk9HTnGlNaszd7HnUnb5FcZjefd8_QdvnM9V</recordid><startdate>20011116</startdate><enddate>20011116</enddate><creator>Peaston, A E</creator><creator>Gardaneh, M</creator><creator>Franco, A V</creator><creator>Hocker, J E</creator><creator>Murphy, K M</creator><creator>Farnsworth, M L</creator><creator>Catchpoole, D R</creator><creator>Haber, M</creator><creator>Norris, M D</creator><creator>Lock, R B</creator><creator>Marshall, G M</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20011116</creationdate><title>MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells</title><author>Peaston, A E ; Gardaneh, M ; Franco, A V ; Hocker, J E ; Murphy, K M ; Farnsworth, M L ; Catchpoole, D R ; Haber, M ; Norris, M D ; Lock, R B ; Marshall, G M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c546t-2cdde2df73a15738de2e16d6ff77416d7ed3a2e8265e6d0e0db12d0ad6da91ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Acids</topic><topic>Antineoplastic agents</topic><topic>Apoptosis</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Cell death</topic><topic>Cell Differentiation</topic><topic>Cell Division</topic><topic>Chemotherapy</topic><topic>Clone Cells</topic><topic>Cloning</topic><topic>Cytotoxicity</topic><topic>Dose-Response Relationship, Drug</topic><topic>Down-Regulation</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>Gene Expression</topic><topic>General aspects</topic><topic>Humans</topic><topic>In Situ Nick-End Labeling</topic><topic>Laboratories</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Microscopy, Fluorescence</topic><topic>Molecular Medicine</topic><topic>MRP1 gene</topic><topic>Multidrug Resistance-Associated Proteins - genetics</topic><topic>Multidrug Resistance-Associated Proteins - metabolism</topic><topic>Multidrug Resistance-Associated Proteins - physiology</topic><topic>Neuroblastoma</topic><topic>Neuroblastoma - metabolism</topic><topic>Neuroblastoma - pathology</topic><topic>Oligonucleotides, Antisense - genetics</topic><topic>Oncology</topic><topic>Pharmacology. Drug treatments</topic><topic>Proteins</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>Regular</topic><topic>regular-article</topic><topic>Transfection</topic><topic>Tretinoin - antagonists &amp; inhibitors</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peaston, A E</creatorcontrib><creatorcontrib>Gardaneh, M</creatorcontrib><creatorcontrib>Franco, A V</creatorcontrib><creatorcontrib>Hocker, J E</creatorcontrib><creatorcontrib>Murphy, K M</creatorcontrib><creatorcontrib>Farnsworth, M L</creatorcontrib><creatorcontrib>Catchpoole, D R</creatorcontrib><creatorcontrib>Haber, M</creatorcontrib><creatorcontrib>Norris, M D</creatorcontrib><creatorcontrib>Lock, R B</creatorcontrib><creatorcontrib>Marshall, G M</creatorcontrib><collection>SpringerOpen</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peaston, A E</au><au>Gardaneh, M</au><au>Franco, A V</au><au>Hocker, J E</au><au>Murphy, K M</au><au>Farnsworth, M L</au><au>Catchpoole, D R</au><au>Haber, M</au><au>Norris, M D</au><au>Lock, R B</au><au>Marshall, G M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>2001-11-16</date><risdate>2001</risdate><volume>85</volume><issue>10</issue><spage>1564</spage><epage>1571</epage><pages>1564-1571</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>We have previously reported a strong correlation between poor prognosis in childhood neuroblastoma (NB) patients and high-level expression of the transmembrane efflux pump, Multidrug Resistance-associated Protein (MRP1), in NB tumour tissue. In this study, we inhibited the endogenous expression of MRP1 in 2 different NB tumour cell lines by stably transfecting an MRP1 antisense expression vector ( MRP -AS). Compared with control cells, MRP -AS transfectant cells demonstrated a higher proportion of dead and morphologically apoptotic cells, spontaneous neuritogenesis, and, increased synaptophysin and neurofilament expression. Bcl-2 protein expression was markedly reduced in MRP -AS cells compared to controls. Conversely, we found that the same NB tumour cell line overexpressing the full-length MRP1 cDNA in sense orientation ( MRP -S) demonstrated resistance to the neuritogenic effect of the differentiating agent, all- trans -retinoic acid. Taken together, the results suggest that the level of MRP1 expression in NB tumour cells may influence the capacity of NB cells for spontaneous regression in vivo through cell differentiation and death. © 2001 Cancer Research Campaign http://www.bjcancer.com</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>11720446</pmid><doi>10.1054/bjoc.2001.2144</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0920
ispartof British journal of cancer, 2001-11, Vol.85 (10), p.1564-1571
issn 0007-0920
1532-1827
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2363953
source Open Access: PubMed Central
subjects Acids
Antineoplastic agents
Apoptosis
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cell death
Cell Differentiation
Cell Division
Chemotherapy
Clone Cells
Cloning
Cytotoxicity
Dose-Response Relationship, Drug
Down-Regulation
Drug Resistance
Epidemiology
Gene Expression
General aspects
Humans
In Situ Nick-End Labeling
Laboratories
Medical research
Medical sciences
Microscopy, Fluorescence
Molecular Medicine
MRP1 gene
Multidrug Resistance-Associated Proteins - genetics
Multidrug Resistance-Associated Proteins - metabolism
Multidrug Resistance-Associated Proteins - physiology
Neuroblastoma
Neuroblastoma - metabolism
Neuroblastoma - pathology
Oligonucleotides, Antisense - genetics
Oncology
Pharmacology. Drug treatments
Proteins
Proto-Oncogene Proteins c-bcl-2 - metabolism
Regular
regular-article
Transfection
Tretinoin - antagonists & inhibitors
Tumor Cells, Cultured
title MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T23%3A30%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MRP1%20gene%20expression%20level%20regulates%20the%20death%20and%20differentiation%20response%20of%20neuroblastoma%20cells&rft.jtitle=British%20journal%20of%20cancer&rft.au=Peaston,%20A%20E&rft.date=2001-11-16&rft.volume=85&rft.issue=10&rft.spage=1564&rft.epage=1571&rft.pages=1564-1571&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1054/bjoc.2001.2144&rft_dat=%3Cproquest_pubme%3E954576083%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c546t-2cdde2df73a15738de2e16d6ff77416d7ed3a2e8265e6d0e0db12d0ad6da91ab3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=229962996&rft_id=info:pmid/11720446&rfr_iscdi=true